Latest | F'cast | |
---|---|---|
Div Yield | 1.2% | 0.0% |
Div Cover | 1.6 | 2.6 |
Op Mrgn | 15.2% | 21.2% |
ROCE | 46.6% |
Latest | F'cast | |
---|---|---|
P/E | 49.4 | 29.6 |
PEG | 7.9 | 0.4 |
Pr/Revenue | 4.7 | 4.4 |
Pr/Book | 7.1 |
Latest | F'cast | |
---|---|---|
Revenue | 13.6% | 7.4% |
PBT | 13.5% | 76.0% |
EPS | 6.3% | 66.6% |
DPS | 5.0% | 4.7% |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Sep-20 | 538.40 | 66.70 | 56.40p | 39.0 | n/a | -12% | 30.00p | 1.4% |
30-Sep-21 | 787.40 | 96.60 | 85.20p | 33.4 | 0.7 | +51% | 42.60p | 1.5% |
30-Sep-22 | 1,012.80 | 129.50 | 107.50p | 21.6 | 0.8 | +26% | 53.80p | 2.3% |
30-Sep-23 | 1,200.30 | 155.60 | 90.80p | 33.1 | n/a | -16% | 56.50p | 1.9% |
30-Sep-24 | 1,363.40 | 176.60 | 96.50p | 45.9 | 7.7 | +6% | 59.30p | 1.3% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Sep-25 | 1,464.67 | 310.82 | 160.74p | 29.6 | 0.4 | +67% | 62.12p | 0.0% |
30-Sep-26 | 1,539.55 | 331.30 | 172.46p | 27.6 | 3.8 | +7% | 65.21p | 0.0% |
30-Sep-27 | 1,617.82 | 348.64 | 182.19p | 26.1 | 4.6 | +6% | 68.41p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Director/PDMR Shareholding | 21-May-2025 | 16:07 | RNS |
Half-year Report | 20-May-2025 | 07:00 | RNS |
Holding(s) in Company | 19-May-2025 | 11:02 | RNS |
Drug shares on a high | 19-Nov-2006 | Scotland on Sunday |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
21-May-25 | Buy | Katie Bickerstaffe | 4,867.00p | 44 | £2,141.48 |
20-May-25 | Buy | Katie Bickerstaffe | 4,982.00p | 13 | £647.66 |
20-May-25 | Buy | Katie Bickerstaffe | 4,981.00p | 39 | £1,942.59 |
Currency | UK Pounds |
Share Price | 4,764.00p |
Change Today | -110.00p |
% Change | -2.26 % |
52 Week High | 4,874.00 |
52 Week Low | 3,624.00 |
Volume | 469,918 |
Shares Issued | 134.18m |
Market Cap | £6,392m |
Beta | 0.01 |
RiskGrade | 165 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 3 |
Buy | 5 |
Neutral | 3 |
Sell | 1 |
Strong Sell | 0 |
Total | 12 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 29-May-25 | 16-Jan-25 |
Paid | 13-Jun-25 | 31-Jan-25 |
Amount | 18.20p | 42.00p |
Time | Volume / Share Price |
16:27 | 11 @ 4,806.00p |
16:37 | 309 @ 4,764.09p |
16:37 | 2,500 @ 4,764.00p |
16:37 | 19 @ 4,764.00p |
16:37 | 8,209 @ 4,764.00p |
You are here: research